(NOVN) Novartis - Performance 9.1% in 12m
Compare NOVN with Indices, Sectors and Commodities and Bonds. Who performs better in which timeframe?
Performance Rating
51.87%
#15 in Group
Rel. Strength
59.39%
#3242 in Universe
Total Return 12m
9.09%
#54 in Group
Total Return 5y
49.96%
#34 in Group
P/E 19.2
54th Percentile in Group
P/E Forward 13.5
47th Percentile in Group
PEG 1.29
56th Percentile in Group
FCF Yield 5.77%
90th Percentile in Group
12m Total Return: NOVN (9.1%) vs XLV (1.7%)

5y Drawdown (Underwater) Chart

Top Performers in Pharmaceuticals
Overall best picks of Peer Group Selected by proven GARP Predictive Metrics, sorted by Growth Rating
Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability |
EPS CAGR |
---|---|---|---|---|---|---|---|---|
CORT NASDAQ Corcept Therapeutics |
-37.1% | 208% | 466% | 57.7 | 43.5 | 0.61 | 55.9% | 3.42% |
LLY NYSE Eli Lilly |
8.84% | 15.8% | 523% | 75.7 | 38.9 | 1.41 | 41.1% | 48.6% |
NVS NYSE Novartis |
1.8% | 21.1% | 74.9% | 19.2 | 13.7 | 1.3 | 35.8% | 4.22% |
SFZN SW Siegfried Holding |
8.63% | 12.1% | 131% | 24.1 | 22.1 | 1.41 | 66.7% | 72.5% |
NOVN SW Novartis |
-4.14% | 9.09% | 50% | 19.2 | 13.5 | 1.29 | 35.8% | 3.8% |
SOBI ST Swedish Orphan Biovitrum |
1.95% | 2.66% | 56.9% | 24.7 | 20.6 | 1.59 | 7.30% | 30.4% |
SAN PA Sanofi |
-5.91% | 7.31% | 26.6% | 18.5 | 11.2 | 0.9 | -20.4% | 16.2% |
SUPN NASDAQ Supernus Pharmaceuticals |
-0.82% | 7.91% | 46.7% | 24.4 | 20.2 | 1.47 | -13.6% | -12.5% |
Performance Comparison: NOVN vs XLV vs S&P 500
XLV (Health Care Sector SPDR ETF) is the Sector Benchmark for NOVN
Total Return (including Dividends) | NOVN | XLV | S&P 500 |
---|---|---|---|
1 Month | -4.14% | -3.79% | -0.87% |
3 Months | 1.64% | -3.99% | -7.58% |
12 Months | 9.09% | 1.72% | 11.88% |
5 Years | 49.96% | 55.40% | 110.33% |
Trend Score (consistency of price movement) | NOVN | XLV | S&P 500 |
1 Month | -6.0% | -3.2% | 23% |
3 Months | -13.3% | -71.4% | -88.5% |
12 Months | 7.70% | -17.5% | 55.1% |
5 Years | 91.2% | 89.8% | 84.1% |
Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XLV | vs. S&P 500 |
1 Month | #120 | -0.36% | -3.30% |
3 Month | #52 | 5.86% | 9.97% |
12 Month | #54 | 7.25% | -2.49% |
5 Years | #34 | -3.50% | -28.7% |
FAQs
Does NOVN Novartis outperforms the market?
Yes,
over the last 12 months NOVN made 9.09%, while its related Sector, the Health Care Sector SPDR (XLV) made 1.72%.
Over the last 3 months NOVN made 1.64%, while XLV made -3.99%.
Over the last 3 months NOVN made 1.64%, while XLV made -3.99%.
Performance Comparison NOVN vs Indeces and Sectors
NOVN vs. Indices NOVN is Over or Underperforming
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
US S&P 500 | SPY | -0.39% | -3.27% | 5.42% | -2.79% |
US NASDAQ 100 | QQQ | -1.42% | -5.54% | 4.99% | -3.58% |
US Dow Jones Industrial 30 | DIA | 0.55% | -0.96% | 5.51% | -0.11% |
German DAX 40 | DAX | 0.84% | -5.46% | -14.1% | -15.6% |
Shanghai Shenzhen CSI 300 | CSI 300 | 3.57% | -1.32% | 8.41% | 3.13% |
Hongkong Hang Seng | HSI | 0.60% | -4.20% | 3.50% | -4.80% |
India NIFTY 50 | INDA | 2.45% | -8.20% | 5.13% | 6.02% |
Brasil Bovespa | EWZ | 0.41% | -8.74% | 1.72% | 14.9% |
NOVN vs. Sectors NOVN is Over or Underperforming
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
Communication Services | XLC | -0.64% | -3.09% | -0.71% | -14.9% |
Consumer Discretionary | XLY | -0.47% | -4.04% | 2.91% | -4.23% |
Consumer Staples | XLP | 3.11% | -4.34% | 0.11% | -2.11% |
Energy | XLE | 4.09% | 9.72% | 11.2% | 20.2% |
Financial | XLF | 1.0% | -2.03% | -2.18% | -13.6% |
Health Care | XLV | -0.31% | -0.35% | 7.11% | 7.37% |
Industrial | XLI | -0.81% | -4.25% | 4.71% | -0.50% |
Materials | XLB | 0.22% | -1.71% | 12.8% | 12.6% |
Real Estate | XLRE | 1.13% | -2.83% | 6.31% | -9.0% |
Technology | XLK | -2.84% | -5.83% | 8.76% | 1.36% |
Utilities | XLU | 2.45% | -4.20% | 3.30% | -12.7% |
Aerospace & Defense | XAR | -1.34% | -10.5% | -8.11% | -17.5% |
Biotech | XBI | -1.69% | -6.42% | 18.1% | 10.9% |
Homebuilder | XHB | 0.30% | -1.87% | 20.2% | 16.1% |
Retail | XRT | 1.18% | -3.58% | 11.0% | 11.8% |